The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,740,378 in first-year total cost, median $547,678.
Most frequent study sections
- Special Emphasis Panel[ZRG1 BST-F (55)]3
Most frequent institutions
- CASE WESTERN RESERVE UNIVERSITY1
- SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE1
- SCRIPPS FLORIDA1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2021 | HTS for the discovery of activators of NK cell cytotoxicity1R01CA259011-01 | WALD, DAVID | CASE WESTERN RESERVE UNIVERSITY, OH | $454,818 | ZRG1 |
| 2019 | Identification of REV-ERB inverse agonists for cancer immunotherapy1R01CA241816-01 | SCAMPAVIA, LOUIS DANIELSOLT, LAURA A | SCRIPPS FLORIDA, FL | $547,678 | ZRG1 |
| 2018 | Early development of small molecule dendritic cell immunopotentiators for the treatment of solid tumors1R01CA229818-01 | CHANDA, SUMIT KGARCIA-SASTRE, ADOLFO | SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE, CA | $737,882 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.